Drugs · Entity Annotation Prototype (beta)

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: tumour necrosis factor inhibitors ×

tumour necrosis factor inhibitors

This drug is selected. Its supporting articles are shown below.

Tumour necrosis factor inhibitors2

Articles mentioning tumour necrosis factor inhibitors

2 articles · page 1 of 1

Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry

rmdopen · abstract · 2026-05-18 · 1 matching annotations

85.4%

interleukin 6 inhibitors b/tsDMARDs tumour necrosis factor inhibitors CTLA4-Ig Janus kinase (JAK) inhibitors rheumatoid arthritis b/tsDMARDs

… The proportion ineligible differed by b/tsDMARDs, highest with interleukin 6 inhibitors (47.4%) and CTLA4-Ig (45.1%) and lowest with Janus kinase (JAK)…

TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccination

rmdopen · abstract · 2025-08-04 · 1 matching annotations

76.3%

TNFi TNFi-treated Tumour necrosis factor inhibitors IBD inflammatory bowel disease (IBD)rheumatoid arthritis immune-mediated inflammatory diseases (IMIDs)vaccination